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Coculturing of Rat Islet Cells with Human Amnion 
Membrane to Increase Their Cell Viability and 
Production of Insulin 
Abstract 
In nowadays, Diabetes Mellitus is a growing threat to humans’ health. Unfortunately, 
there is no permanent and effective cure for it. Usually, transplantations of Langerhans islets or 
pancreases are not successful in long terms because of immune sytems attack on them. The aim 
of this research is to find out the potential of usage of human amnion membrane as a protective 
membrane against the immune system in islet transplantations. No research similar to this one 
has been done which means that this study is the first one in literature. My research question is 
“How does human amnion membrane affect rat langerhans islet’s cell viability and 
functionability during coculture by fluorescent microscopy and glucose stimulation test?”.  
 The HAM (Human Amnion Membrane) is the inner layer of the placenta that surrounds 
the baby during pregnancy. HAM shares its cellular origin with the fetus; together they grow in 
parallel throughout pregnancy. It supports cell growth and repairing processes. It is cheap and 
because of its extensive usage in wound clothing, especially in eye wound clothing, it is easy 
to find. For these reasons, HAM is a good candidate for be used as a protective membrane in 
langerhans islet transplantations. 
 During the experiment, 3 experiment group and one control group was taken to coculture 
with HAM and HAM position in respect to the islets was different in each group. Before the 
culture, cell viability and insulin indexes of experiment groups were measured by fluorescent 
microscopy and glucose stimulation test. After 48 hours in coculture, cell viability and glucose 
stimulation tests were done again to measure the final cell viability and insulin indexes of 
experiment groups. Inıitial cell viability and insulin indexes are 81.0% and 3.4 respectively G2 
(has no insert solution between islets and HAM) has the lowest final mean cell viability (%64)  
and index of insulin (2.2) in the experiment groups. Control group’s (only islets) final index of 
insulin and mean cell viability are 3.7 and %82 respectively. G3 (islets at the top, HAM at the 
bottom, includes insert) has the second highest final mean cell viability (%86)  and index of 
insulin (4.2). G1 has the highest final mean cell viability (%93) and index of insulin (5.8). 
Standard error of control group’s final cell viability is 0.63, standard error of final cell viability 
of G1 is 0.90, G2 ‘s standard error of final cell viability is 1.23 and standard error of final cell 
viability of G3 is 0.63. Standard error of control group’s final insulin index is 0.36, standard 
error of insulin index of G1 is 0.33, G2 ‘s standard error of final insulin index is 0.14 and 
standard error of final cell viability of G3 is 0.06.P value of one way ANOVA test of cell 
viability and glucose stimulation test are (p= 4.73 X 10-12, p= 1.19 X 10-16 ) respectively. These 
p values are smaller that alpha value which means  HAM can be used as a protective membrane 
in Langerhans islet transplantations. 
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Introduction 
 The first time that I heard about the diabetes was when I learned that my mother had 
gestational diabetes during her pregnancy. In order to prevent possible complications that could 
create severe problems, she followed a strict diet and managed to pass her pregnancy without 
any problem. Her disease inspired me to make a research on diabetes. 
 I found an article in internet when I was searching diabetes. The article was about DM 
(Diabetes Mellitus) type I. While I was reading the article, I noticed for the first time that there 
was no permanent cure exists for type 1 but some treatments to hide its symptoms. Although 
patients get permanent cure in some cases by langerhans islets or pancreas transplantation, their 
success rate is low and patients need immunosuppressive drugs for the rest of their life. This 
problem attracted my attention to DM Type I and I decided to focus on this subject. 
 Type I diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a 
chronic condition in which the pancreas produces little or no insulin, a hormone needed to allow 
sugar (glucose) to enter cells to produce energy. Various factors may contribute to type 
1diabetes, including genetics and exposure to certain viruses.1 These factors attack to β cells of 
Langerhans islets which are responsible for production of insulin. 
 Human islets of Langerhans are complex micro-organs responsible for maintaining 
glucose homeostasis. Islets contain five different endocrine cell types, which react to changes 
in plasma nutrient levels with the release of a carefully balanced mixture of islet hormones into 
the portal vein.2 In the human pancreas, 65 to 90 percent of islet cells are beta cells, 15 to 20 
percent are alpha-cells, 3 to 10 percent are delta cells, and one percent is PP cells. 3 
Main treatment of DM Type I is the insulin therapy which is the injection of insulin by 
a syringe, insulin pen or insulin pump to keep the blood sugar level stabile. This therapy 
continues in the rest of the patient’s life. There are some medications except insulin to protect 
organs from secondary damage of DM Type I. In addition to insulin therapy and medications, 
Type I patients must pay attention to their diet and they must make physical exercise. 
 These treatments usually enough to hide the symptoms of the Type 1 but after for a long 
time, the body may develop resistance to insulin injections. In order to overcome the resistance, 
                                                            
1 http://www.mayoclinic.com/health/type‐1‐diabetes/DS00329 
 
2 In't Veld P, Marichal M, Microscopic anatomy of the human islet of Langerhans., 2010 
 
3 http://stemcells.nih.gov/info/scireport/pages/chapter7.aspx 
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higher amounts of insulin and other drugs are used which is harmful and cause kidney failure 
in some cases which may cause to death. 
 In order to cure DM Type I for once and for all, several types of transplantations have 
been tried on Type I patients. First one of them is the pancreas transplantation. Main goal of the 
pancreas transplantation is to make the body produce its own insulin by its new pancreas’ β 
cells. Pancreas-only transplants require lifelong immunosuppression to prevent rejection of the 
graft and potential recurrence of the autoimmune process that might again destroy pancreatic 
islet cells. Immunosuppressive regimens used in transplant patients have side effects whose 
frequency and severity restrict their use to patients who have serious progressive complications 
of diabetes or whose quality of life is unacceptable. In addition to the side effects of lifelong 
immunosuppression, the procedure itself has significant morbidity and carries a small, but not 
negligible, risk of mortality.4 
 Second one is the islet transplantation. Researchers are experimenting with islet cell 
transplantation, which provides new insulin-producing cells from a donor pancreas. 
Unfortunately, islet cell transplantation still requires the use of immune-suppressing 
medications, and just as it did with its own natural islet cells, the body often destroys 
transplanted islet cells, making the time off injected insulin short-lived.5 
 Between these two, islet transplantations offer the lowest risk and it is more economic. 
The problem is despite of usage of immuno-suppressing medications, it may not be possible to 
protect islets for a long time. Because, the factor that destroyed the patient’s own islets (immune 
system, virus, bacteria or toxics) usually still in the body and destroys the islets again.If they 
are somehow protected, then the main complication that causes the long term failure of the islet 
transplantations will be disappear and these transplantations might offer  higher success rates 
to the patients.   
While I was searching DM Type I, I read that a protective membrane that encloses 
langerhans islets after the langerhans islets transplantation might be able to protect them from 
external threats such as bacterial or viral infection, toxics and immune system. Unfortunately, 
there are many important characteristics that a protective membrane must have. First of all, it 
must allow the diffusion of respiratory gases, cellular wastes and nutritients in order to allow 
the islets to make the necessary matter exchange. Secondly, this membrane must be 
antinflamatuar because any immunologic reaction against the membrane can harm both 
membrane and islets. In addition to these characteristics, this membrane should be cheap, easy 
to produce and avaible if it will be used in general treatment of DM Type I. 
. The HAM (Human Amnion Membrane) is the inner layer of the placenta that surrounds 
the baby during pregnancy. HAM shares its cellular origin with the fetus; together they grow in 
parallel throughout pregnancy. The Amniotic Membrane is the only tissue designed by nature 
specifically as a universal transplant, protecting the baby and ensuring acceptance by the 
                                                            
4 R. Paul Robertson, MD; Connie Davis, MD; Jennifer Larsen, MD; Robert Stratta, MD; and 
David E.R. Sutherland, MD, Pancreas Transplantation for Patients With Type 1 Diabetes, 
DIABETES CARE, VOLUME 26, SUPPLEMENT 1, JANUARY 2003 
5 http://www.mayoclinic.com/health/type‐1‐diabetes/DS00329/DSECTION=treatments‐and‐
drugs 
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mother’s immune system. Human Amniotic Membrane has been used in medicine for more 
than 100 years. Thanks to its usage for a very long time it is definitely known that HAM has no 
side effects.5 Previous researches show that HAM allows diffusion of glucose. It supports cell 
growth and repairing processes. It is cheap and because of its extensive usage in wound 
clothing, especially in eye wound clothing, it is easy to find. For these reasons, HAM is a good 
candidate for be used as a protective membrane in langerhans islet transplantations. 
 The aim of this research is to find out the potential of usage of human amnion membrane 
as a protective membrane in islet transplantations. No research similar to this one has been done 
which means that this study is the first one in literature.  
My research question is “How does human amnion membrane affect rat langerhans 
islet’s cell viability and functionability during coculture by fluorescent microscopy and glucose 
stimulation test?”. 
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Hypothesis  
 
 Human amnion membrane has been used for wound dressing for a century. It supports 
cell growth. Most importantly, it does not allow leukocytes to pass through which is very 
important to protect islets after the transplantation. Human amnion membrane has no antigen 
which makes it antinflammatory. It is derived from placenta after birth which makes it easy to 
find. It is easy to store and very basic and small number of procedures and required to use it in 
transplantation. 6 Thanks to these characteristics, it is very economic. Previous researches 
showed that HAM allows diffusion of glucose and insulin. I believe that all of these 
characteristics make HAM a very good candidate to                                                                                   be 
used as a protective membrane in islet transplantations. It is hypothesized that staying in 
coculture of islet cells &HAM increases the viability and insulin production (insulin index) of 
islet cells indicated by fluorescent microscopy and glucose stimulation test. Null hypothesis of 
this research is that presence of HAM creates no difference in cell viability and insulin index 
of langerhans islets. 
 
 
 
 
 
 
 
 
 
 
                                                            
6 Tseng and ark., 1998; Meller and ark., 2000 
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Method Development 
 Research question of this research is “How does human amnion membrane affect rat 
langerhans islet’s cell viability and functionability during coculture by fluorescent microscopy 
and glucose stimulation test?”. My first step on designing the method was designing the culture 
conditions. I had two option of coculture: indirect coculture and direct coculture. The difference 
between them is that there is a physical contact between human amnion membrane and islets in 
direct coculture but there is a chemical interaction between HAM and islets rather than physical 
contact in indirect coculture. I decided to use both of them because both of these coculture 
methods can be applied to islet transplantation and presence or lack of physical contact may 
affect the experiment results. Next step was deciding what kind of medium do I use during the 
culture of HAM and islets. RPMI 1640 medium is preferred in mammalian cell and tissue 
cultures and it does not contain animal serum that may intergene with the characteristics of 
islets of langerhans cells. These properties make RPMI 1640 medium a very suitable medium 
for my research and my reasons for choosing RPMI 1640 medium. Standard temperature, 
moisture and CO2 concentration of a mammalian cell culture are 36 0C, %95 moisture and %5 
CO2 and because of these are the optimum conditions for the culture of islet cells; I set these 
conditions in the incubator. 
 After the design of the culture conditions, I designed the experiment groups. In order to 
evaluate and analyze the effects of HAM by comparing results of HAM-included cultures with 
not HAM-included cultures, I decided to create a controll group (group C). There are two groups 
of indirect coculture, in group 1 (G1), langerhans islets are at the bottom of the well and HAM 
is on the topside of the well. They are seperated by insert solution. The second group with 
indirect coculture (G3) is same but positions of HAM and islets are different in respect to 
position of each others. In G3, islets are at the top and HAM is at the bottom. My reason for 
using two experiment groups with indirect coculture is to find out does the position of HAM in 
respect to the islets have any effect on islets. Because if there are any negative effects caused 
by position of HAM in respect to the islets, HAM might partially damage islets during the 
transplantation and makes the transplantation inefficient because although body starts to 
produce its own insulin, it won’t be enough and exogenous insulin injection would be still 
required.  
 There is one experiment group of direct coculture (G2). The reason of why there is only 
one experiment group of direct coculture is that effect of position of HAM in respect to the 
islets will be determined by indirect experiment groups, so I did not need two experiment groups 
of direct coculture. 
 Perhaps, the most important step was deciding how to measure the effects of human 
amnion membrane on islet cells because choosing wrong parameters may not show the true 
effects of HAM or show no effect at all. I think that knowing HAM’s effect on cell viability is 
crucial because if it harms islets, there is no sense to use it as a protective membrane. Also, it 
is very important to know the impacts of presence of HAM in coculture on production of insulin 
of β cells of islets because the aim of islet transplantations is to give the abilitiy of producing 
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its own insulin to body and any negative effect of HAM on insulin production of  β cells makes 
the transplantation useless.  
 After deciding the parameters of effects of HAM, I chose the test to measure those 
parameters. There are many tests for measuring cell viability but fluorescent microscopy as it 
is very precise and it does not only measure cell viability but also differentiate the dead and 
alive cells. The location of the dead cells may indicate presence/absence of external damage or 
lack of oxygen and such causes of damage on islets. In order to measure the effects of HAM on 
insulin production of islets, I decided to use glucose stimulation test. My reason was that 
glucose stimulation test is precise, accurate and easy to do. The hardest step of the designing 
the method for me was designing the preparation of HAM for the experiment. I made a lot of 
research and spend many hours to design the method. You can find it at Appendix B. 
 Presence of microorganisms or any toxic material can harm or destroy all of the islets 
during the culture. In order to avoid such harms, the experiment was conducted in the rat 
langerhans islet lab of Dışkapı Training and Research Hospital. With Dr. Ferda Alparslan’s 
permission, I chose Dışkapı Training and Research Hospital’s Rat Langerhans Islet Lab to 
conduct my research because they have the every instrument that I need and demand no money 
for the expenses of my research. 
 The lab was hygienic and any instrument was washed with %70 alcohol disinfentents 
before using it in order to kill all of the microorganisms and prevent any contamination. All 
ltubes, wells, chemical and biological material have not been used before to eliminate the 
possibility of contamination of toxic materials and microorganisms. As I mentioned before, the 
lab was hygienic to prevent contamination. 
 This experiment had been conducted for 48 hours. I consider several factors while 
making this decision. My priority was to conduct the experiment long enough to see the 
significant effects of HAM. Because of nutrients in the culture is limited, if I choose too long 
time, islets might starve and die which may hide the positive effects of HAM. I also considered 
that concentration of cellular waste can reach to dangerous levels for islets if they stay in the 
culture for a long time, and again hide the positive effects of HAM.  
 The impact of deviation due strictly to chance is diminshed as the sample size increases.7 
I thought that measuring cell viability and production of insulin for 5 times diminshes the 
impact of deviation due strictly to chance enough. Although it did not create a significant 
problem, due to the malfunction of instruments, glucose stimulation test was performed for 3 
times for every experiment group. 
 After the experiment, in order to evaluate the results, it is essential to know that the 
difference between results of the experiment groups are significant or not. I decided to use One-
Way ANOVA test to calculate that the difference is significant or not because it is used for 
calculation the mean difference between two or more samples. 
                                                            
7 S. Klug William, Concepts of Genetics, Prentice Hall,1997 
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 Materials used in Experiment 
L‐Glutamin,  
Penisilin/ Streptomisin/ Ampisilin,  
FBS (Fetal Bovine Serum),  
Roswell Park Memorial Medium, 
Propidium Iodide,  
PBS,  
Fluorescein diacetate,  
Aceton,  
Glucose 
Indirect coculture dishes 
Rat Langerhans Islets 
Human Amnion Membrane 
DMEM‐ LG with % 50 glicerol  
Tripsin‐ETDA C 
Pasteur pipettes 
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Method 
Steps of the Method 
A.Fluorescent microscopy before the experiment 
Cell viabilities of islets of experiment groups before the culture are measured by fluorescent 
microscopy. (Procedure is described in Appendix A) 
B. Glucose stimulation test before the experiment 
This research’s main goal to find a possible cure to DM Type 1 and because of that, effect of 
HAM on insulin production capacity of β cells of Langerhans islets was determined. In order 
to do this, insulin production capacity of β cells was measured at both before and after the 
experiment by glucose stimulation test. (Procedure is described in Appendix C) 
C. Preparation of Human Amnion Membrane 
 HAM was provided by Dışkapı Training and Research Hospital. To prepare it for the 
experiment, it was washed by different solutions and to separate amnion epithel, it was treated 
with EDTA solution. Detailed protocol is included in Appendix B. 
D. Preparing the culture 
Next step is was preparing cocultures of HAM and Langerhans islets. There are 4 experiment 
groups. These are control group, G1,G2,G3. (The procedure is described in Appendix D). 
 
Figure 1: Figure shows experimental groups in culturing HAM and islet cells. Totally 4 groups 
tested for viability assays: Control group (no HAM), G1 (HAM at the top and islets are at the 
bottom, no physical contact), G2 (HAM at the top and islets are at the bottom, physical contact 
is present), G3 (HAM at the bottom and islets are at the top, no physical contact) 
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E. Fluorescent microscopy after the experiment 
Cell viabilities of islets of experiment groups after the culture are measured by fluorescent 
microscopy. (Procedure is described in Appendix A) 
F. Glucose stimulation test after the experiment 
Insulin indexes of islets of experiment groups after the culture are measured by glucose 
stimulation test. (Procedure is described in Appendix B) 
 
 
 
 
Figure 2: Main steps of the experiment 
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5.Results 
 
 
 
 
 
 
Table 1:This table shows the cell viability of islets of experiment groups before the culture (Hour 
0)  
Time  Control Group  Group 1  Group 2    Group 3   
Number of terms  5  5  5    5   
Mean  81.0  81.0  81.0    81.0   
Mode   81.0  none  none    80 
            
Median  81.0  81.0  81.0    80.0   
Range   6  4  6    8   
Variance  3.9  2.0  5.2    7.2   
Standart deviation  1.97  1.41  2.28    2.68   
95%  confidence 
interval  78.628‐83.372  79.249‐82.751
78.169‐
83.831 
 
 
77.672‐
84.328 
 
 
Standard Error  0.88  0.63  1.00 
1.20
 
 
Table 2: Statistics of values of cell viability of each group before the culture 
  Cell  viability  of 
Control  Group 
(%) 
Cell  viability  of 
Group 1(%) 
Cell  viability  of 
Group 2(%) 
Cell  viability  of 
Group (%) 
Sample 1  82.0  95.0  68.0  86.0 
Sample2  81.0  93.0  64.0  84.0 
Sample 3  83.0  91.0  61.0  88.0 
Sample 4  84.0  95.5  61.0  85.0 
Sample 5  80.0  90.5  66.0  87.0 
Table 3: Table 1:This table shows the cell viability of islets of experiment groups after the culture
(Hour 48) 
 
 
 
Time   Cell viability of 
Control Group 
Cell viability of 
Group 1 
Cell viability of 
Group 2 
Cell viability of 
Group 3 
Hour 0  %83.5  %80.0  %84.0  %78.0 
%81.0  %82.0  %81.0  %80.0 
%82.0  %83.0  %78.0  %86.0 
%81.0  %79.0  %83.0  %80.0 
%77.5  %81.0  %79.0  %81.0 
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Control 
Group     Group 1    Group 2  Group 3 
Number of terms  5    5    5  5 
mean  82.0    93.0    64.0  86.0 
Mode   none    none    61  none 
Median  82.0    93.0    64.0  86.0 
Range   4    5    7  4 
Variance  2.0    4.1    7.6  2.0 
Standart deviation  1.41    2.02    2.75  1.41 
95%  confidence 
interval 
80.249‐
83.751 
 
 
90.492‐
95.508 
 
 
60.585‐
67.415 
84.249‐
87.751 
Standard Error  0.63 
0.90
 
1.23
  0.63 
Table 4: Statistics of values of cell viability for each group after culture. 
 
 
Graph 1: Results of florescent microscopy test ,which shows the cell viabilities of islet cells 
for each group, before and after the experiment. 
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 Control Group G1 G2 G3 
Sample 1 5.9 6.1 5.7 6.1 
Sample 2 6.8 9.7 6.3 6.8 
Sample 3 5.9 5.8 5.8 5.7 
Sample 4 6.1 6.6 6.0 6.2 
Sample 5 6.3 6.8 6.2 6.5 
Table 5: This table demonstrates the ng of insulin per ml in each groups’ 3.3 Mm glucose 
solution after one hour of incubation of islets in those glucose solutions before the coculture.
Time    Control Group  Group 1  Group 2    Group 3 
Number of terms    5  5  5  5   
Mean    6.2  7.0  6.0    6.26 
Mode     5.9  ‐  ‐    ‐ 
    6.1  6.6  6.0    6.2 
Median             
Range     0.9  3.9  0.6    1.1 
Variance    0.11  1.95  0.05    0.14 
Standart deviation    0.33  1.40  0.23    0.37 
95%  confidence 
interval 
 
  5.91‐6.49  5.77‐8.23  5.71  6.29   
Standard error 
0.14 
  0.63  0.10  0.17   
Table 6: Statistics of values of insulin per ml in 3.3 Mm glucose solution for each group 
before culture. 
 Control Group G1 G2 G3 
Sample 1 20.5 24.1 20.1 19.6 
Sample 2 24.7 23.2 18.2 21.7 
Sample 3 18.5 27.1 24.1 22.9 
Sample 4 19.9 25.1 19.2 23.4 
Sample 5 22.5 24.6 22.6 19.9 
Table 7: This table demonstrates the ng of insulin per ml in each groups’ 16.7 Mm glucose 
solution after one hour of incubation of islets in those glucose solutions before the coculture.
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Time  Control Group  Group 1  Group 2    Group 3 
Number of terms  5  5  5  5   
Mean  21.2  24.8  20.8  21.5   
Mode   ‐  ‐  ‐  ‐   
  20.5  24.6  20.1  21.7   
Median           
Range   6.2  3.9  5.9  3.8   
Variance  4.68  1.69  4.79  2.36   
Standart deviation  2.16  1.30  2.19  1.53   
95%  confidence 
interval  18.52‐23.88  23.19‐26.41  18.08 
16.60‐
23.40   
Standard error  0.97  0.58  0.98  0.68   
Table 8: Statistics of values of insulin per ml in 16.7 Mm glucose solution for each group 
before culture. 
 
 Control Group G1 G2 G3 
Sample 1 7.6 9.8 3.4 8.2 
Sample 2 6.1 11.3 4.1 8.1 
Sample 3 8.5 12.1 3.2 8.3 
Sample 4 7.9 11.2 3.3 8.4 
Sample 5 7.2 11.1 3.5 8.0 
Table 9: This table demonstrates the ng of insulin per ml in each groups’ 3.3 Mm glucose 
solution after one hour of incubation of islets in those glucose solutions after the coculture.
Time    Control Group  Group 1  Group 2 
Group 
3 
Number of terms    5  5  5  5 
Mean    7.5  11.1  3.5  8.2 
Mode     ‐  ‐  ‐  ‐ 
    7.6  11.2  3.4  8.2 
Median           
Range     2.4  2.3  0.9  0.4 
Variance    0.64  0.55  0.10  0.02 
Standart deviation    0.80  0.74  0.32  0.14 
95% confidence interval
 
  6.50‐8.49  10.18‐12.02  3.10‐3.90 
8.03‐
8.37 
Standard Error 
0.36 
  0.33  0.14  0.06 
Table 10: Statistics of values of insulin per ml in 3.3 Mm glucose solution for each group 
after culture 
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 Control Group G1 G2 G3 
Sample 1 27.3 67.6 7.8 34.4 
Sample 2 26.8 59.8 7.1 39.2 
Sample 3 26.1 65.9 8.3 31.3 
Sample 4 27.2 66.2 8.2 34.3 
Sample 5 26.8 63.7 8.4 36.7 
Table 11: This table demonstrates the ng of insulin per ml in each groups’ 16.7 Mm glucose 
solution after one hour of incubation of islets in those glucose solutions after the coculture.
Time    Control Group  Group 1  Group 2  Group 3 
Number of terms    5  5  5  5 
Mean    26.8  64.6  8.0  35.2 
Mode     26.8  ‐  ‐  ‐ 
    26.8  65.9  8.2  34.4 
Median           
Range     1.2  7.8  1.3  7.9 
Variance    0.18  7.41  0.23  6.98 
Standart deviation    0.42  2.72  0.48  2.64 
95% confidence interval
 
  26.28‐27.32  61.22‐67.98  7.40‐8.60 
31.92‐
38.478 
Standard Error 
 
0.19  1.22  0.21  1.18 
Table 12: Statistics of values of insulin per ml in 16.7 Mm glucose solution for each group 
after culture. 
 
 
 Control Group G1 G2 G3 
Initial Index of 
Insulin 
3.42 3.54 3.47 3.43 
Final Index of 
Insulin 
3.59 5.82 2.21 4.29 
Table 13: Initial and final index of insulin of experiment groups 
001129‐0053 Umut Taşdelen 
 
18 
 
Graph 3: Initial and final index of insulin of experiment groups 
 
Anova 
Variance 
source 
 
  SS  df    MS  F  P‐value  F critical 
Between 
Groups 
 
  2293,75  3    764,5833 155,8386 4,73E‐12 3,238872 
Within Groups    78,5  16    4,90625       
                 
                 
Total     2372,25  19               
Table 14: One-way ANOVA analysis of fluorescent microscopy ,which shows the cell 
viabilities of islet cells for each group, results 
             
Variance 
source  SS  df  MS  F  P‐value  F critical 
Between 
Groups  8345.366  3  2781.789 601.2728
1.19X10‐
16  3.238872 
Within Groups  74.024  16  4.6265       
             
Total  8419,39  19             
Table 15: One-way ANOVA analysis of glucose stimulation results 
0
1
2
3
4
5
6
7
Control group Group 1 Group 2 Group 3
Initial Index of Insulin
Final Index of Insulin
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6.Evaluation 
  Main goal of this research was to find out can HAM be used in Langerhans islet 
transplantations for DM Type 1 patients and if it can, with or without a barrier that seperates 
islets and HAM. It was hypothesized that there would be a slightly difference between cell 
viability and capacity of producing insulin of groups that contains insert solution because area 
of the bottom of a well is slightly larger than area of the top of the well. It was also hypothesized 
that there might be a significant difference between cell viability and capacity of insulin 
production of insert-included groups and group that contains HAM but no insert (G2) because 
a physical contact between islets and HAM can decrease the access of islets to oxygen and 
damage structure of islets. No significant change on cell viability and capacity of insulin 
production of control group was hypothesized. 
 G2 (has no insert solution between islets and HAM) has the lowest final mean cell 
viability (%64)  and index of insulin (2.2) in the experiment groups. Control group’s (only 
islets) final index of insulin and mean cell viability are 3.7 and %82 respectively. G3 (islets at 
the top, HAM at the bottom, includes insert) has the second highest final mean cell viability 
(%86)  and index of insulin (4.2). G1 has the highest final mean cell viability (%93) and index 
of insulin (5.8). Standard error of control group’s final cell viability is 0.63, standard error of 
final cell viability of G1 is 0.90, G2 ‘s standard error of final cell viability is 1.23 and standard 
error of final cell viability of G3 is 0.63. Standard error of control group’s final insulin index is 
0.36, standard error of insulin index of G1 is 0.33, G2 ‘s standard error of final insulin index is 
0.14 and standard error of final cell viability of G3 is 0.06. 
 In order to determine the difference between cellof  viability of experiment groups after 
the coculture is significant or not, I used one-way ANOVA test. As a results of ANOVA test 
which you can see at table 14, p value is smaller than alpha value ( p= 4.73 X 10-12 < α = 0,05), 
the difference is significant in terms of statistics. So, ANOVA test rejects H0 hypothesis (null 
hypothesis) which is there is no significant difference between means of cell viability of 
experiment groups after the coculture and supports the hypothesis which is there is a significant 
difference between means of viability of experiment groups after the coculture. Also, ANOVA 
test of glucose stimulation rejects H0 hypothesis ( p= 1.19 X 10-16 < α = 0,05) which suggests 
that there is no significant difference between glucose index of insulin. Standard error of 
experiment results was low which indicates that number of trials is enough. More trials can be 
done for performing statistical analysis more deeply to improve the investigation. 
My background information, my hypothesis and results of the experiment are 
compatible. But I believe that method of this experiment can be improved by the changes below: 
1. Roswell Park Memorial Institue Medium (RPMI 1640) created no problem 
during my research. However to obtain better results, Dubecco’s Modified 
Eagle’s Medium (DMEM), or HamF12 medium  can be used in further 
researches to evaluate the effect of other growthmediums. It is essential that 
these mediums must be serum free. 
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2. I believe that smaller area of the top of the wells in respect to their bottom created 
the difference between cell viability and insulin indexes of G1 (amnion 
membrane is at the top and islets are at the bottom of wells) and G3 (islets are at 
the top and amnion membrane is at the bottom). Usage of wells that their area of 
the top is equal to their bottom’s area may prevent that difference in further 
researches. 
3. In order to see the difference between insulin indexes of different experiment 
groups, glucose molarity of solutions can be changed in glucose stimulation 
tests. This change would increase the insulin indexes of experiment groups 
therefore shows the difference between experiment groups better. 
It was expected that physical contact of Langerhans islets and HAM would cause a 
significant decrease in cell viability and index of insulin, but its significance surprises me 
because such damage to islets by the physical contact was not expected. Under these 
circumstances, I believe it is safe to presume that HAM damages islets are deadly affected in 
the presence of a physical contact. 
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7.Conclusion 
 My research question is “How does human amnion membrane affect rat langerhans 
islet’s cell viability and functionability during coculture by fluorescent microscopy and glucose 
stimulation test?” was answered by the experimental results of my investigation. There is a 
significant relationship between presence of human amnion membrane in coculture and cell 
viability, index of insulin of rat langerhans islets. In the absence of a physical contact, human 
amnion membrane improves both cell viability and index of insulin of rat langerhans but in the 
presence of physical contact, it decreases cell viability and index of insulin. 
 Reason of why I chose this subject was suggesting a new way of treatment of Diabetes 
Mellitus Type I with lower price and higher success rate.  Results of this experiment shows that 
islets transplantations with HAM as a protective membrane might be the cure of DM Type I. 
Therefore, my research created a new hope for DM Type I patients.  
 However, before the trials of the islet transplantation with HAM, there are many 
questions that has to be answered. Perhaps, the most important one is how to use HAM as a 
protective membrane. My investigation answered the question “can HAM be used as a 
protective membrane in islet transplantations?” but it does not answer “how to use HAM as a 
protective membrane?”. Fortunately, it gives a very important clue which is there should not be 
a physical contact between islets and HAM. It is possible to prevent any physical contact by 
using cell encapsulation.   Cell microencapsulation technology involves immobilization of the 
cells within a polymeric semi-permeable membrane that permits the bidirectional diffusion of 
molecules such as the influx of oxygen, nutrients, growth factors etc. essential for 
cell metabolism and the outward diffusion of waste products and therapeutic proteins. At the 
same time, the semi-permeable nature of the membrane prevents immune cells 
and antibodies from destroying the encapsulated cells regarding them as foreign invaders.8 
These unique characteristics of cell encapsulation makes it very possible to be used in future 
islet transplantations. This research is admitted to Biotechnology Congress of European Union 
2013 in Bratislava and I have presented it in Commenius University in Bratislava. 
                                                            
8 http://en.wikipedia.org/wiki/Cell_encapsulation 
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Figure 2: A diagram of cell encapsulation 
 Between the membrane and cells, there is a matrix. The further researches should focus 
on which substance can form this matrix because its characteristics are crucial on the life time 
of islets. Then, it is important to decide how to create the semi permable membrane from 
amnion membrane and later produce. 
 Another important question is  where to transplant the Langerhans islets. This question 
has a very high significance because without the correct location of transplantation, no matter 
how effective the islet transplantation, islets would not provide insulin, cannot get nutrients and 
die and eventually the therapy would fail. Therefore, further researches also should focus on 
this question.  If all these goals achieved, then islet transplantations with HAM on animal 
subjects can be tried.  
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Appendix A: Fluorescent microscopy 
At the very beginning of the experiment, islets were separated to 4 groups which are G0, G1, G2 
and G3.In order to measure initial cell viability of langerhans islets of these groups, florescent 
microscopy test was used. First, 918 µL PBS (Fetal Bovine Serum) (Ph 7,4) was added to 35 
mm petri dishes in order to create a suitable medium for islets to keep their cell viability constant 
during the test. If their cell viability would not be constant, then there would be significant error 
in the test results. Second step was adding 90 µL from islet cultures to petri dish. After that 20 
µL FDA solution and 20 µL PI solution was added to dish. Next step was keeping the petri dish 
in a dark room for 5 minutes. Then, it was observed under 40X floruscent microscope. FDA 
can only pass through cell membrane of alive cells and under light that has 490 nm wavelength, 
it emits green florescent light. Because of these characteristics, under 490 nm light, FDA mark 
alive cells. PI connects itself to the DNA of autolysed cells and under 536nm light, it emits red 
florescent light. These characteristics make PI a useful tool for marking dead cells by a 
florescent microscope.  
 During florescent microscopy, 5 islets photos were taken twice, one under 490 nm light, 
other one was under 536 nm light. Then, red and green light ratios of the photos were analysed 
separately. Islets green light (alive cell) and red light (dead cell) ratios were calculated by colour 
analysed code of Matlab. 
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Appendix B: Preparation of Human Amnion Membrane 
Amnion membrane was provided by Dışkapı Research and Training Hospital Stem Cell 
Center Amnion Membrane Bank. Before the experiment, membrane was washed in 100 µg/ml 
Penicillin and 100 µg/ml streptomisin PBS (phosphate buffer saline) solution. After separating 
epitel and basal membrane from other tissues, membrane was divided to 10 parts and stored in 
a low glucose (1g/L) DMEM-LG solution with %50 glycerol. Before the experiment, in order 
to separate amnion epithel, membrane pieces were kept in a %0.02 EDTA (Tripsin-EDTAC) 
which has %0.25 tripsin for 30 minutes. After this process, membrane was ready for the 
experiment. 
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Appendix C: Glucose Stimulation Test 
 At the beginning of the glucose stimulation test, 150µL islet and 100 µL insert was 
added to a well for 13 times. Solution was checked for any islets that was dropped from the 
insert and put back to there by handpick if there was any. Then, 3.3 mM or 16.7Mm glucose 
solution was added to islets till volume of the new solution (islets+insert+glucose) became 5 
ml. After this step, islets were incubated at 370 C in a 95% CO2 incubator for an hour and 
solutions were put to ependorf tubes from wells after noting their experiment group and 
molarity of glucose solution. These samples were centrifuged at 1800 rpm for 1 minutes and 
400 µL samples were taken from all tubes. These samples were stored at -200 C for Elisa kit. 
Insulin index is calculated by using the formula below: 
݉݁ܽ݊	݊݃	݋݂	݅݊ݏݑ݈݅݊	݌݁ݎ	݈݉	݅݊	16.7	݉ܯ	ܩ݈ݑܿ݋ݏ݁	ܵ݋݈ݑݐ݅݋݊/݉݁ܽ݊	݊݃	݋݂	݅݊ݏݑ݈݅݊	݌݁ݎ	݈݉	݅݊	3.3	݉ܯ	ܩ݈ݑܿ݋ݏ݁	ܵ݋݈ݑݐ݅݋݊ 
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Appendix D: Preparing the Cultures 
There are two different possible methods for langerhans islet transplantations with HAM 
based on interaction of HAM with islets. At the first method, there is no barrier between islets 
and HAM. In order to simulate conditions of islets in this method, islets were at the bottom of 
the well and HAM was placed on islets without any insert to separate them(G2). Second method 
(incapsulation) includes a barrier between islets and HAM to separate them and prevent 
possible damage to islets because of results of physical contact. Insert solution separated islets 
and HAM in two experiment groups. At one of these groups, islets were at the bottom and 
membrane was on the top(G1), islets were at the top and HAM was on the bottom at the other 
group(G3). In order to decide the effect of HAM on islets of HAM-included experiment groups, 
a control group was prepared which did not have HAM but only islets(Control Group). RPMI 
(+) solution was added to all experiment groups. Islets were incubated at 370C, %5 CO2 and 
%95 moisture for 48 hours. After incubation, florescent microscopy and glucose stimulation 
tests were repeated. 
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Appendix E: Photos from experiment 
 
 
 
001129‐0053 Umut Taşdelen 
 
28 
 
Bibliography 
1.http://www.mayoclinic.com/health/type-1-diabetes/DS00329 
 
2.In't Veld P, Marichal M, Microscopic anatomy of the human islet of Langerhans., 2010 
 
3.http://stemcells.nih.gov/info/scireport/pages/chapter7.aspx 
4.R. Paul Robertson, MD; Connie Davis, MD; Jennifer Larsen, MD; Robert Stratta, MD; and 
David E.R. Sutherland, MD, Pancreas Transplantation for Patients With Type 1 Diabetes, 
DIABETES CARE, VOLUME 26, SUPPLEMENT 1, JANUARY 2003 
5.http://www.mayoclinic.com/health/type-1-diabetes/DS00329/DSECTION=treatments-and-
drugs 
6.S. Klug William, Concepts of Genetics, Prentice Hall,1997 
7.http://en.wikipedia.org/wiki/Cell_encapsulation 
8.http://en.wikipedia.org/wiki/Cell_encapsulation 
9. Tseng and ark., 1998; Meller and ark., 2000 
 
 
 
 
 
 
 
 
 
 
